Cyclacel Pharma (CYCC) Reports Q4 Loss of $0.10/Share
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Price: $6.37 --0%
Financial Fact:
Selling, general and administrative: 1.27M
Today's EPS Names:
YRD, NNOX, BB, More
Financial Fact:
Selling, general and administrative: 1.27M
Today's EPS Names:
YRD, NNOX, BB, More
Join SI Premium – FREE
Cyclacel Pharma (NASDAQ: CYCC) reported Q4 EPS of ($0.10), versus ($0.21) reported last year. Revenue for the quarter came in at $424 thousand, versus $247 thousand reported last year.
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
- JPMorgan Starts Accton Technology Corp. (2345:TT) at Overweight
- Qualcomm expects $40bn in non-handset revenue by fiscal 2029
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
